BIO5's Dr. John Galgiani, founding director of the UA Valley Fever Center of Excellence, lead multiple free talks for professionals and the public during Valley Fever Awareness Week. UA Valley Fever Center for Excellence continues pressing forward in efforts to get a potentially curative anti-valley fever drug, nikkomycin Z, or NikZ, into clinical trials.
